Reidy Christopher R 4

What Happened Christopher R. Reidy, a non-employee director of Encompass Health Corp (EHC), recorded two acquisitions. On 2026-07-15 he was credited 21 restricted stock units (RSUs) tied to the company dividend (reported at $0.00 per share). On 2026-07-16 he acquired 319 shares at $112.40 each, a purchase totaling $35,856 under the company’s directors’ deferred stock plan. Both transactions are reported as acquisitions/awards (code A).

Key Details

• Transaction dates and amounts:
  • 2026-07-15: 21 RSUs credited @ $0.00 (dividend-related award).
  • 2026-07-16: 319 shares acquired @ $112.40 each = $35,856.
• Dividend and price used for RSU crediting: dividend $0.19 per share (paid 7/15/2026); closing price used for the RSU calculation was $109.88 (per filing footnote).
• Shares owned after the transactions: Not specified in this Form 4.
• Footnotes:
  • F1: The 21 RSUs were credited under outstanding RSU award agreements as a dividend-equivalent—number of RSUs equals dividend amount divided by closing price on the dividend payment date.
  • F2: The 319 shares were purchased by the Directors Deferred Stock Investment Plan using director fee deferrals and the reinvested dividend; purchases were made in the market by the plan administrator.
• Filing timeliness: Report filed 2026-07-16 for transactions on 2026-07-15 and 07-16 — appears timely (no late filing indicated).

Context These are director compensation/deferral-related acquisitions rather than open-market purchases initiated directly by the director. RSU credits tied to dividends and purchases via a directors’ deferral plan are common and reflect routine compensation deferral and dividend reinvestment, not necessarily a separate personal investment decision.